G3

SMAIO SAFRA SMAIO Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

0.033

Micro

Exchange

XFRA - Deutsche Boerse AG

G3O.F Stock Analysis

G3

Uncovered

SMAIO SA is uncovered by Eyestock quantitative analysis.

Market cap $B

0.033

Dividend yield

Shares outstanding

5.229 B

S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes and currently employs 30 full-time employees. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software,

View Section: Eyestock Rating